{"id":63088,"date":"2023-09-19T15:30:40","date_gmt":"2023-09-19T19:30:40","guid":{"rendered":"https:\/\/ifintechworld.com\/investing\/boston-scientific-to-acquire-relievant-medsystems-for-850-million-upfront-plus-milestone-payments\/"},"modified":"2023-09-19T15:30:42","modified_gmt":"2023-09-19T19:30:42","slug":"boston-scientific-to-acquire-relievant-medsystems-for-850-million-upfront-plus-milestone-payments","status":"publish","type":"post","link":"https:\/\/ifintechworld.com\/?p=63088","title":{"rendered":"Boston Scientific to acquire Relievant Medsystems for $850 million upfront, plus milestone payments"},"content":{"rendered":"<div id=\"js-article__body\" itemprop=\"articleBody\" data-sbid=\"WP-MKTW-0002519294\" role=\"document\">\n<p>Boston Scientific Corp.<br \/>\n        BSX,<br \/>\n        <bg-quote field=\"percentchange\" format=\"0,000.00%\" channel=\"\/zigman2\/quotes\/203726728\/composite\" class=\"positive\">+0.15%<\/bg-quote><br \/>\n       said Tuesday it has entered an agreement to acquire Relievant Medsystems Inc., a privately held medical tech company that has developed a treatment for a form of chronic low back pain.  Boston Scientific will pay $850 million upfront and additional but undisclosed contingent payments based on reaching certain sales goals over the next three years. Relievant has developed the Intracept (R) Intraosseous Nerve Ablation System to treat vertebrogenic pain, the only such treatment to win U.S. Food and Drug Administration approval for that condition. \u201cThe therapy uses targeted radiofrequency energy to stop the basivertebral nerve from transmitting pain signals to the brain and is designed to improve function and provide long-term relief,\u201d the company said in a statement. About 5.3 million people living in the U.S. suffer from vertebrogenic pain. The deal is expected to close in the first half of 2024 and to generate sales of more than $70 million in 2023 and growth of more than 50% in 2024. The deal is expected to be immaterial to adjusted per-share earnings in 2024, slightly accretive in 2025 and increasingly accretive after that. The stock was up 0.9% premarket and has gained 14.6% in the year to date, while the S&amp;P 500<br \/>\n        SPX,<br \/>\n        <bg-quote field=\"percentchange\" format=\"0,000.00%\" channel=\"\/zigman2\/quotes\/210599714\/realtime\" class=\"negative\">-0.26%<\/bg-quote><br \/>\n       has gained 16%. <\/p>\n<\/div>\n<p>Read the full article <a href=\"https:\/\/www.marketwatch.com\/story\/boston-scientific-to-acquire-relievant-medsystems-for-850-million-upfront-plus-milestone-payments-1558a6c0?mod=investing\" target=\"_blank\" rel=\"noopener\">here<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston Scientific Corp. BSX, +0.15% said Tuesday it has entered an agreement to acquire Relievant Medsystems Inc., a privately held medical tech company that has developed a treatment for a form of chronic low back pain. Boston Scientific will pay $850 million upfront and additional but undisclosed contingent payments based on reaching certain sales goals [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1383,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"video","meta":{"footnotes":""},"categories":[239],"tags":[83],"class_list":["post-63088","post","type-post","status-publish","format-video","has-post-thumbnail","hentry","category-investing","tag-featured","post_format-post-format-video"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v20.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Boston Scientific to acquire Relievant Medsystems for $850 million upfront, plus milestone payments | iFintechWorld<\/title>\n<meta name=\"description\" content=\"Boston Scientific Corp. BSX, +0.15% said Tuesday it has entered an agreement to acquire Relievant Medsystems Inc., a privately held medical tech company\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ifintechworld.com\/?p=63088\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Boston Scientific to acquire Relievant Medsystems for $850 million upfront, plus milestone payments | iFintechWorld\" \/>\n<meta property=\"og:description\" content=\"Boston Scientific Corp. BSX, +0.15% said Tuesday it has entered an agreement to acquire Relievant Medsystems Inc., a privately held medical tech company\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ifintechworld.com\/?p=63088\" \/>\n<meta property=\"og:site_name\" content=\"iFintechWorld\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-19T19:30:40+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-09-19T19:30:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/MW-GP644_MicroS_ZG_20180906154215.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1320\" \/>\n\t<meta property=\"og:image:height\" content=\"742\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"News Room\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"News Room\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ifintechworld.com\/?p=63088#article\",\"isPartOf\":{\"@id\":\"https:\/\/ifintechworld.com\/?p=63088\"},\"author\":{\"name\":\"News Room\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61\"},\"headline\":\"Boston Scientific to acquire Relievant Medsystems for $850 million upfront, plus milestone payments\",\"datePublished\":\"2023-09-19T19:30:40+00:00\",\"dateModified\":\"2023-09-19T19:30:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ifintechworld.com\/?p=63088\"},\"wordCount\":219,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/ifintechworld.com\/#organization\"},\"keywords\":[\"Featured\"],\"articleSection\":[\"Investing\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ifintechworld.com\/?p=63088#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ifintechworld.com\/?p=63088\",\"url\":\"https:\/\/ifintechworld.com\/?p=63088\",\"name\":\"Boston Scientific to acquire Relievant Medsystems for $850 million upfront, plus milestone payments | iFintechWorld\",\"isPartOf\":{\"@id\":\"https:\/\/ifintechworld.com\/#website\"},\"datePublished\":\"2023-09-19T19:30:40+00:00\",\"dateModified\":\"2023-09-19T19:30:42+00:00\",\"description\":\"Boston Scientific Corp. BSX, +0.15% said Tuesday it has entered an agreement to acquire Relievant Medsystems Inc., a privately held medical tech company\",\"breadcrumb\":{\"@id\":\"https:\/\/ifintechworld.com\/?p=63088#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ifintechworld.com\/?p=63088\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ifintechworld.com\/?p=63088#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ifintechworld.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Boston Scientific to acquire Relievant Medsystems for $850 million upfront, plus milestone payments\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ifintechworld.com\/#website\",\"url\":\"https:\/\/ifintechworld.com\/\",\"name\":\"Repay Down\",\"description\":\"Latest Personal Finance News, Tips and Updates\",\"publisher\":{\"@id\":\"https:\/\/ifintechworld.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ifintechworld.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ifintechworld.com\/#organization\",\"name\":\"Repay Down\",\"url\":\"https:\/\/ifintechworld.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png\",\"contentUrl\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png\",\"width\":558,\"height\":90,\"caption\":\"Repay Down\"},\"image\":{\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61\",\"name\":\"News Room\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png\",\"contentUrl\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png\",\"caption\":\"News Room\"},\"sameAs\":[\"https:\/\/ifintechworld.com\"],\"url\":\"https:\/\/ifintechworld.com\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Boston Scientific to acquire Relievant Medsystems for $850 million upfront, plus milestone payments | iFintechWorld","description":"Boston Scientific Corp. BSX, +0.15% said Tuesday it has entered an agreement to acquire Relievant Medsystems Inc., a privately held medical tech company","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ifintechworld.com\/?p=63088","og_locale":"en_US","og_type":"article","og_title":"Boston Scientific to acquire Relievant Medsystems for $850 million upfront, plus milestone payments | iFintechWorld","og_description":"Boston Scientific Corp. BSX, +0.15% said Tuesday it has entered an agreement to acquire Relievant Medsystems Inc., a privately held medical tech company","og_url":"https:\/\/ifintechworld.com\/?p=63088","og_site_name":"iFintechWorld","article_published_time":"2023-09-19T19:30:40+00:00","article_modified_time":"2023-09-19T19:30:42+00:00","og_image":[{"width":1320,"height":742,"url":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/MW-GP644_MicroS_ZG_20180906154215.jpg","type":"image\/jpeg"}],"author":"News Room","twitter_card":"summary_large_image","twitter_misc":{"Written by":"News Room","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ifintechworld.com\/?p=63088#article","isPartOf":{"@id":"https:\/\/ifintechworld.com\/?p=63088"},"author":{"name":"News Room","@id":"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61"},"headline":"Boston Scientific to acquire Relievant Medsystems for $850 million upfront, plus milestone payments","datePublished":"2023-09-19T19:30:40+00:00","dateModified":"2023-09-19T19:30:42+00:00","mainEntityOfPage":{"@id":"https:\/\/ifintechworld.com\/?p=63088"},"wordCount":219,"commentCount":0,"publisher":{"@id":"https:\/\/ifintechworld.com\/#organization"},"keywords":["Featured"],"articleSection":["Investing"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ifintechworld.com\/?p=63088#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ifintechworld.com\/?p=63088","url":"https:\/\/ifintechworld.com\/?p=63088","name":"Boston Scientific to acquire Relievant Medsystems for $850 million upfront, plus milestone payments | iFintechWorld","isPartOf":{"@id":"https:\/\/ifintechworld.com\/#website"},"datePublished":"2023-09-19T19:30:40+00:00","dateModified":"2023-09-19T19:30:42+00:00","description":"Boston Scientific Corp. BSX, +0.15% said Tuesday it has entered an agreement to acquire Relievant Medsystems Inc., a privately held medical tech company","breadcrumb":{"@id":"https:\/\/ifintechworld.com\/?p=63088#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ifintechworld.com\/?p=63088"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ifintechworld.com\/?p=63088#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ifintechworld.com\/"},{"@type":"ListItem","position":2,"name":"Boston Scientific to acquire Relievant Medsystems for $850 million upfront, plus milestone payments"}]},{"@type":"WebSite","@id":"https:\/\/ifintechworld.com\/#website","url":"https:\/\/ifintechworld.com\/","name":"Repay Down","description":"Latest Personal Finance News, Tips and Updates","publisher":{"@id":"https:\/\/ifintechworld.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ifintechworld.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ifintechworld.com\/#organization","name":"Repay Down","url":"https:\/\/ifintechworld.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/","url":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png","contentUrl":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png","width":558,"height":90,"caption":"Repay Down"},"image":{"@id":"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61","name":"News Room","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ifintechworld.com\/#\/schema\/person\/image\/","url":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png","contentUrl":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png","caption":"News Room"},"sameAs":["https:\/\/ifintechworld.com"],"url":"https:\/\/ifintechworld.com\/?author=1"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts\/63088","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=63088"}],"version-history":[{"count":1,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts\/63088\/revisions"}],"predecessor-version":[{"id":63089,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts\/63088\/revisions\/63089"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/media\/1383"}],"wp:attachment":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=63088"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=63088"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=63088"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}